Autocrine endothelin-3/endothelin receptor B signaling maintains cellular and molecular properties of glioblastoma stem cells

Molecular Cancer Research

Volumn 9, Issue 12, 2011, Pages 1668-1685

  Liu, Yue ^a   Ye, Fei ^a,b   Yamada, Kazunari ^a   Tso, Jonathan L ^a   Zhang, Yibei ^a   Nguyen, David H ^a   Dong, Qinghua ^a,c   Soto, Horacio ^a   Choe, Jinny ^a   Dembo, Anna ^a   Wheeler, Hayley ^a   Eskin, Ascia ^a   Schmid, Ingrid ^a   Yong, William H ^a   Mischel, Paul S ^a   Cloughesy, Timothy F ^a   Kornblum, Harley I ^a   Nelson, Stanley F ^a   Liau, Linda M ^a   Tso, Cho Lea ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR B; PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; YKL 40 PROTEIN;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL SURVIVAL; CYTOSKELETON; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GLIOBLASTOMA; GLIOBLASTOMA STEM CELL; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEURAL CREST CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; STEM CELL;

ANIMALS; APOPTOSIS; AUTOCRINE COMMUNICATION; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL TRANSFORMATION, NEOPLASTIC; ENDOTHELIN-3; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENE REGULATORY NETWORKS; GENOME, HUMAN; GLIOBLASTOMA; HUMANS; MICE; MICE, SCID; NEOPLASTIC STEM CELLS; NEURAL CREST; RECEPTOR, ENDOTHELIN B; RNA, SMALL INTERFERING;

EID: 84055182507     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0563     Document Type: Article

References (50)

1. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK, et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001;15:1311-33. (Pubitemid 32524640)
2. Beier D, Hau P, Proescholdt M, Lohmeier A, Wischhusen J, Oefner PJ, et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells showdifferential growth characteristics and molecular profiles. Cancer Res 2007;67:4010-5. (Pubitemid 46815044)
3. Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008;27:2897-909. (Pubitemid 351620450)
4. Hemmati HD, Nakano I, Lazareff JA, Masterman-Smith M, Geschwind DH, Bronner-Fraser M, et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 2003;100: 15178-83. (Pubitemid 37518036)
5. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004; 432:396-401. (Pubitemid 39551674)
6. Wang J, Sakariassen PØ, Tsinkalovsky O, Immervoll H, Bøe SO, Svendsen A, et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. Int J Cancer 2008;122: 761-8.
7. Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004;64: 7011-21. (Pubitemid 39331011)
8. Liu Q, Nguyen DH, Dong Q, Shitaku P, Chung K, Liu OY, et al. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J Neurooncol 2009;94:1-19.
9. Yuan X, Curtin J, Xiong Y, Liu G, Waschsmann-Hogiu S, Farkas DL, et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 2004;23:9392-400. (Pubitemid 40069671)
10. Bao S,WuQ, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006;444:756-60.
11. Murat A, Migliavacca E, Gorlia T, Lambiv WL, Shay T, Hamou MF, et al. Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma. J Clin Oncol 2008;26:3015-24.
12. Lahav R, Dupin E, Lecoin L, Glavieux C, Champeval D, Ziller C, et al. Endothelin 3 selectively promotes survival and proliferation of neural crest-derived glial and melanocytic precursors in vitro. Proc Natl Acad Sci USA 1998;95:14214-9. (Pubitemid 28549347)
13. Stone JG, Spirling LI, Richardson MK. The neural crest population responding to endothelin-3 in vitro includes multipotent cells. J Cell Sci 1997;110:1673-82. (Pubitemid 27338755)
14. Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev 1994;46:325-415.
15. Shimada K, Matsushita Y, Wakabayashi K, Takahashi M, Matsubara A, Iijima Y, et al. Cloning and functional expression of human endothelin-converting enzyme cDNA. Biochem Biophys Res Commun 1995; 207:807-12.
16. Bagnato A, Catt KJ. Endothelins as autocrine regulators of tumor cell growth. Trends Endocrinol Metab 1998;9:378-83. (Pubitemid 28489837)
17. Leibl MA, Ota T, Woodward MN, Kenny SE, Lloyd DA, Vaillant CR, et al. Expression of endothelin 3 by mesenchymal cells of embryonic mouse caecum. Gut 1999;44:246-52. (Pubitemid 29119369)
18. Levin ER. Endothelins. N Engl J Med 1995;333:356-63.
19. Edery P, Attié T, Amiel J, Pelet A, Eng C, Hofstra RM, et al. Mutation of the endothelin-3 gene in the Waardenburg-Hirschsprung disease (Shah-Waardenburg syndrome). Nat Genet 1996;12:442-4. (Pubitemid 26105938)
20. McCallion AS, Chakravarti A. EDNRB/EDN3 and Hirschsprung disease type II. Pigment Cell Res 2001;14:161-9. (Pubitemid 32931054)
21. Brand M, Le Moullec JM, Corvol P, Gasc JM. Ontogeny of endothelins-1 and -3, their receptors, and endothelin converting enzyme-1 in the early human embryo. J Clin Invest 1998;101:549-59. (Pubitemid 28084237)
22. Nagy N, Goldstein AM. Endothelin-3 regulates neural crest cell proliferation and differentiation in the hindgut enteric nervous system. Dev Biol 2006;293:203-17.
23. Egidy G, Eberl LP, Valdenaire O, Irmler M, Majdi R, Diserens AC, et al. The endothelin system in human glioblastoma. Lab Invest 2000; 80:1681-9.
24. Tsutsumi K, Niwa M, Kitagawa N, Yamaga S, Anda T, Himeno A, et al. Enhanced expression of an endothelin ETA receptor in capillaries from human glioblastoma: a quantitative receptor autoradiographic analysis using a radioluminographic imaging plate system. J Neurochem 1994;63:2240-7.
25. Bhalla A, Haque S, Taylor I, Winslet M, Loizidou M. Endothelin receptor antagonism and cancer. Eur J Clin Invest 39 Suppl 2009;2:74-77.
26. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50. (Pubitemid 41528093)
27. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, Donin NM, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006;9:391-403. (Pubitemid 43668737)
28. Sun de J, Liu Y, Lu DC, Kim W, Lee JH, Maynard J, et al. Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells. Hum Pathol 2007; 38:1047-56.
29. Wiesmann F, Veeck J, Galm O, Hartmann A, Esteller M, Knüchel R, et al. Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer. Breast Cancer Res 2009; 11:R34.
30. Kurtz A, Zimmer A, Schnütgen F, Brüning G, Spener F, Müller T, et al. The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development 1994;120:2637-49. (Pubitemid 24268837)
31. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci USA 2000;97:14720-5. (Pubitemid 32016642)
32. Ellis P, Fagan BM, Magness ST, Hutton S, Taranova O, Hayashi S, et al. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci 2004;26:148-65. (Pubitemid 40867972)
33. Yun K, Mantani A, Garel S, Rubenstein J, Israel MA. Id4 regulates neural progenitor proliferation and differentiation in vivo. Development 2004;131:5441-8. (Pubitemid 39562186)
34. Shen Y, Mani S, Meiri KF. Failure to express GAP-43 leads to disruption of a multipotent precursor and inhibits astrocyte differentiation. Mol Cell Neurosci 2004;26:390-405. (Pubitemid 38968433)
35. Pelloski CE, Mahajan A, Maor M, Chang EL, Woo S, Gilbert M, et al. YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastoma. Clin Cancer Res 2005;11: 3326-34. (Pubitemid 40627883)
36. Mitaka C, Hirata Y, Ichikawa K, Yokoyama K, Emori T, Kanno K, et al. Effects of TNF-alpha on hemodynamic changes and circulating endothelium-derived vasoactive factors in dogs. Am J Physiol 1994;267: H1530-6.
37. Thomson E, Kumarathasan P, Vincent R. Pulmonary expression of preproET-1 and preproET-3 mRNAs is altered reciprocally in rats after inhalation of air pollutants. Exp Biol Med (Maywood) 2006; 231:979-84. (Pubitemid 43845563)
38. Schinelli S, Zanassi P, Paolillo M, Wang H, Feliciello A, Gallo V, et al. Stimulation of endothelin B receptors in astrocytes induces cAMP response element-binding protein phosphorylation and c-fos expression via multiple mitogen-activated protein kinase signaling pathways. J Neurosci 2001;21:8842-53. (Pubitemid 33054848)
39. Shinohara H, Udagawa J, Morishita R, Ueda H, Otani H, Semba R, et al. Gi2 signaling enhances proliferation of neural progenitor cells in the developing brain. J Biol Chem 2004;279:41141-8. (Pubitemid 39287716)
40. Kalabis J, Li G, Fukunaga-Kalabis M, Rustgi AK, Herlyn M. Endothelin-3 stimulates survival of goblet cells in organotypic cultures of fetal human colonic epithelium. Am J Physiol Gastrointest Liver Physiol 2008;295:G1182-9.
41. Böhm M, Moellmann G, Cheng E, Alvarez-Franco M, Wagner S, Sassone-Corsi P, et al. Identification of p90RSK as the probable CREB-Ser133 kinase in human melanocytes. Cell Growth Differ 1995; 6:291-302.
42. Sato-Jin K, Nishimura EK, Akasaka E, Huber W, Nakano H, Miller A, et al. Epistatic connections between microphthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders. FASEB J 2008;22:1155-68. (Pubitemid 351519970)
43. Bagnato A, Rosanò L, Spinella F, Di Castro V, Tecce R, Natali PG, et al. Endothelin B receptor blockade inhibits dynamics of cell interactions and communications in melanoma cell progression. Cancer Res 2004;64:1436-43. (Pubitemid 38235614)
44. WuJJ, Chen JX, Rothman TP, Gershon MD. Inhibition of in vitro enteric neuronal development by endothelin-3: mediation by endothelin B receptors. Development 1999;126:1161-73.
45. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, Malatesta P, et al. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009; 27:40-8.
46. Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, et al. NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells 2010;28:5-16.
47. Bondurand N, Natarajan D, Barlow A, Thapar N, Pachnis V. Maintenance of mammalian enteric nervous system progenitors by SOX10 and endothelin 3 signalling. Development 2006;133: 2075-86. (Pubitemid 43881272)
48. Paolillo M, Russo MA, Curti D, Lanni C, Schinelli S. Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells. Pharmacol Res 2010;61:306-15.
49. Montgomery JP, Patterson PH. Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor. BMC Cancer 2008;8:354-64.
50. Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, Jones PA, et al. The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 2001;10:903-10. (Pubitemid 32401406)